肝移植术后何时出院对短期结局最优:系统综述与专家小组推荐
该指南基于PRISMA系统综述与GRADE方法,由国际专家小组制定,旨在明确肝移植术后出院时机对短期结局(再入院率、30–90天死亡率与发病率)的影响。检索未找到足够证据确定最优出院时机,推荐强度评为弱,且未能就再入院率、30–90天死亡率(6项研究)和30–90天发病率(5项研究)给出推荐方向。结论认为判断最优出院时机证据稀少。在门诊随访健全的中心,术后最早6–8天出院可安全进行(证据质量低,推荐强度弱)。
要点
- 在门诊随访健全的中心,肝移植术后最早6–8天出院可安全进行(证据质量低,推荐强度弱)。
- 系统综述未能就再入院率给出推荐方向,也未确定最优出院时机。
- 关于30–90天死亡率,共6项研究,但未能据此给出推荐方向。
- 关于30–90天发病率,共5项研究,同样未能给出推荐方向。
- 总体证据稀少,推荐强度评为弱,无法判断肝移植术后出院时机对短期结局的最优选择。
适用人群与场景
- 肝移植术后患者,评估出院时机对短期结局(再入院率、30–90天死亡率与发病率)的影响。
处置流程与药物剂量
- 在门诊随访健全的中心,肝移植术后最早6–8天可安全出院(证据质量低,推荐强度弱)。
研究设计与关键结果
- 系统综述遵循PRISMA指南,采用GRADE方法,由国际专家小组制定,PROSPERO注册号CRD42021245598。
- 推荐强度评为弱,未能就再入院率、30–90天死亡率(6项研究)和30–90天发病率(5项研究)给出推荐方向。
- 结论认为判断肝移植术后出院时机对短期结局最优的证据稀少。
证据类型、等级与局限
- 证据类型:系统综述与专家小组推荐(GRADE方法)。
- 证据质量:低;推荐强度:弱。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在门诊随访健全的中心,作者认为肝移植术后最早6–8天出院可安全进行(证据质量低,推荐强度弱)。
- 由于证据稀少,未能就再入院率、30–90天死亡率和30–90天发病率确定最优出院时机。
指南或共识出处
- 指南名称:肝移植术后何时出院对短期结局最优:系统综述与专家小组推荐(Clin Transplant)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Several factors associated with prolonged hospital stay have been described. A recent study demonstrated that hospital length of stay (LOS) is directly associated with an increased cost for liver transplantation (LT) and may be associated with greater mortality; however, the factors associated with post-LT mortality are also related to a prolonged hospital stay, that is, those factors are confounders. Thus, the actual impact of the length of post-LT hospital stay on both short-term and long-term patient and graft survival remains uncertain.
OBJECTIVES: To identify the optimal time to discharge patients after LT with respect to short-term outcomes; readmission rate, 30-90-mortality and morbidity.
METHODS: Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Initial search keywords for screening were as follows; ((discharge AND (time OR "time point" OR "time-point")) OR "length of hospital stay" OR "length of stay") AND ((liver OR hepatic) AND (transplant OR transplantation)).
PROSPERO ID: CRD42021245598 RESULTS: The strength of recommendation was rated as Weak, and we did not identify the direction of recommendations regarding the optimal timing after LT concerning short-term outcomes, including "Readmission rate," six studies on 30- and/or 90-day mortality, and five studies on "30- and/or 90-day morbidity rate."
CONCLUSIONS: Evidence is scarce to judge the optimal timing to discharge patients after LT with respect to short-term outcomes. In centers with robust outpatient follow-up, discharge can occur safely as early as post-transplant 6-8 days (Quality of Evidence [QOE]; Low | Grade of Recommendation; Weak).
参考来源
- Tanaka T, Reichman TW, Olmos A, et al. When is the optimal time to discharge patients after liver transplantation with respect to short-term outcomes? A systematic review of the literature and expert panel recommendations. Clin Transplant. 2022. PMID: 35470472. doi:10.1111/ctr.14685
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。